Document:

EX-4.3

 Exhibit 4.3 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE
SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT
REQUIRED. 
 Void after 

    , 2017 

INOGEN, INC. 
 WARRANT
TO PURCHASE SHARES 
 This Warrant is issued
to                    (“Investor”) by INOGEN, INC, a Delaware corporation (the “Company”), pursuant to the terms of
that certain Series D-1 Preferred Stock Convertible Promissory Note and Warrant Purchase Agreement (the “Note Purchase Agreement”) of even date herewith, in connection with the
Company’s issuance to the holder of this Warrant of a Convertible Promissory Note (the “Note”) and such Investor’s Capital Commitment under the Note Purchase Agreement. Terms used but not defined herein shall have the
meaning ascribed to them in the Note Purchase Agreement. 
 1. Purchase of Shares. Subject to the terms and conditions hereinafter
set forth and set forth in the Note Purchase Agreement, the holder of this Warrant is entitled, upon surrender of this Warrant at the principal office of the Company (or at such other place as the Company shall notify the holder hereof in writing),
to purchase from the Company up to the number of fully paid and nonassessable Shares (as defined below), that equals the quotient obtained by dividing (a) the Warrant Coverage Amount (as defined below) by (b) $0.73. 

2. Definitions. 
 (a)
Exercise Price. The exercise price for the Shares shall be $0.01 per share (such price, as adjusted from time to time, is herein referred to as the “Exercise Price”). 

(b) Exercise Period. This Warrant shall be exercisable, in whole or in part, during the term commencing on the date hereof and ending
on the expiration of this Warrant pursuant to Section 14 hereof. 
 (c) Warrant Coverage Amount. The term “Warrant
Coverage Amount” shall mean that amount which equals the sum of (i) 10% of the Investor’s Capital Commitment under the Note Purchase Agreement, plus (ii) 25% of the principal of all Notes issued to the Investor under the Note
Purchase Agreement in respect of such Investor’s Pro Rata Share (as set forth on Schedule A to the Purchase Agreement) of all amounts raised under the Note Purchase Agreement, plus (iii) 100% of the principal of all Notes issued to the
Investor under the Note Purchase Agreement in respect of principal invested by the Investor in excess of such Investor’s Pro Rata Share of all amounts raised under the Note Purchase Agreement (as set forth on Schedule A to the Purchase
Agreement). For clarity, Schedule A to the Purchase Agreement sets forth an example of the calculation of the Warrant Coverage Amount. 

(d) The Shares. The term “Shares” shall mean Common Stock. 

 (e) Change of Control. The term “Change of Control” is defined in the
corresponding Note. 
 3. Method of Exercise. While this Warrant remains outstanding and exercisable in accordance with
Section 2 above, the holder may exercise, in whole or in part, the purchase rights evidenced hereby. Such exercise shall be effected by: 

(i) the surrender of the Warrant, together with a notice of exercise to the Secretary of the Company at its principal offices; and 

(ii) the payment to the Company of an amount equal to the aggregate Exercise Price for the number of Shares being purchased. 

4. Net Exercise. In lieu of cash exercising this Warrant, the holder of this Warrant may elect to receive shares equal to the value of
this Warrant (or the portion thereof being canceled) by surrender of this Warrant at the principal office of the Company together with notice of such election, in which event the Company shall issue to the holder hereof a number of Shares computed
using the following formula: 
  

					
		  		 	Y (A -B)
	X	  	=	 	      A

 Where: 

X - The number of Shares to be issued to the holder of this Warrant. 

Y - The number of Shares purchasable under this Warrant. 

A - The fair market value of one Share. 

B - The Exercise Price (as adjusted to the date of such calculations). 

For purposes of this Section 4, the fair market value of a Share shall mean the average of the closing bid and asked prices of Shares
quoted in the over-the-counter market in which the Shares are traded or the closing price quoted on any exchange on which the Shares are listed, whichever is applicable, as published in the Western Edition of The Wall Street Journal for the
ten (10) trading days prior to the date of determination of fair market value (or such shorter period of time during which such stock was traded over-the-counter or on such exchange). If the Shares are not traded on the over-the-counter market
or on an exchange, the fair market value shall be the price per Share that the Company could obtain from a willing buyer for Shares sold by the Company from authorized but unissued Shares, as such prices shall be determined in good faith by the
Company’s Board of Directors. 
 5. Certificates for Shares. Upon the exercise of the purchase rights evidenced by this Warrant,
one or more certificates for the number of Shares so purchased shall be issued as soon as practicable thereafter, and in any event within ten (10) days of the delivery of the subscription notice. 

6. Issuance of Shares. The Company covenants that the Shares, when issued pursuant to the exercise of this Warrant, will be duly and
validly issued, fully paid and nonassessable and free from all taxes, liens, and charges with respect to the issuance thereof. 

  
 -2- 

 7. Adjustment of Exercise Price and Number of Shares. The number of and kind of securities
purchasable upon exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time as follows: 
 (a)
Subdivisions, Combinations and Other Issuances. If the Company shall at any time prior to the expiration of this Warrant subdivide the Shares, by split-up or otherwise, or combine its Shares, or issue additional shares of its Shares as a
dividend, the number of Shares issuable on the exercise of this Warrant shall forthwith be proportionately increased in the case of a subdivision or stock dividend, or proportionately decreased in the case of a combination. Appropriate adjustments
shall also be made to the purchase price payable per share, but the aggregate purchase price payable for the total number of Shares purchasable under this Warrant (as adjusted) shall remain the same. Any adjustment under this Section 7(a) shall
become effective at the close of business on the date the subdivision or combination becomes effective, or as of the record date of such dividend, or in the event that no record date is fixed, upon the making of such dividend. 

(b) Reclassification, Reorganization and Consolidation. In case of any reclassification, capital reorganization, or change in the
capital stock of the Company (other than as a result of a subdivision, combination, or stock dividend provided for in Section 7(a) above), then the Company shall make appropriate provision so that the holder of this Warrant shall have the right
at any time prior to the expiration of this Warrant to purchase, at a total price equal to that payable upon the exercise of this Warrant, the kind and amount of shares of stock and other securities and property receivable in connection with such
reclassification, reorganization, or change by a holder of the same number of Shares as were purchasable by the holder of this Warrant immediately prior to such reclassification, reorganization, or change. In any such case appropriate provisions
shall be made with respect to the rights and interest of the holder of this Warrant so that the provisions hereof shall thereafter be applicable with respect to any shares of stock or other securities and property deliverable upon exercise hereof,
and appropriate adjustments shall be made to the purchase price per share payable hereunder, provided the aggregate purchase price shall remain the same. 

(c) Notice of Adjustment. When any adjustment is required to be made in the number or kind of shares purchasable upon exercise of the
Warrant, or in the Exercise Price, the Company shall promptly notify the holder of such event and of the number of Shares or other securities or property thereafter purchasable upon exercise of this Warrant. 

8. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of
this Warrant, but in lieu of such fractional shares the Company shall make a cash payment therefor on the basis of the Exercise Price then in effect. 

9. Representations of the Company. The Company represents that all corporate actions on the part of the Company, its officers,
directors and stockholders necessary for the sale and issuance of this Warrant have been taken. 
 10. Representations and Warranties by
the Holder. The Holder represents and warrants to the Company as follows: 
 (a) This Warrant and the Shares issuable upon exercise
thereof are being acquired for its own account, for investment and not with a view to, or for resale in connection with, any distribution or public offering thereof within the meaning of the Securities Act of 1933, as amended (the
“Act”). Upon exercise of this Warrant, the Holder shall, if so requested by the Company, confirm in writing, in a form satisfactory to the Company, that the securities issuable upon exercise of this Warrant are being acquired for
investment and not with a view toward distribution or resale. 

  
 -3- 

 (b) The Holder understands that the Warrant and the Shares have not been registered under the Act
by reason of their issuance in a transaction exempt from the registration and prospectus delivery requirements of the Act pursuant to Section 4(2) thereof, and that they must be held by the Holder indefinitely, and that the Holder must
therefore bear the economic risk of such investment indefinitely, unless a subsequent disposition thereof is registered under the Act or is exempted from such registration. The Holder further understands that the Warrant Shares have not been
qualified under the California Securities Law of 1968 (the “California Law”) by reason of their issuance in a transaction exempt from the qualification requirements of the California Law pursuant to Section 25102(f) thereof,
which exemption depends upon, among other things, the bona fide nature of the Holder’s investment intent expressed above. 
 (c) The
Holder has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of the purchase of this Warrant and the Shares purchasable pursuant to the terms of this Warrant and of protecting its
interests in connection therewith. 
 (d) The Holder is able to bear the economic risk of the purchase of the Shares pursuant to the terms
of this Warrant. 
 (e) The Holder is an “accredited investor” as such term is defined in Rule 501 of Regulation D promulgated
under the Act. 
 11. Restrictive Legend. 

The Shares (unless registered under the Act) shall be stamped or imprinted with a legend in substantially the following form: 

THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR
DISTRIBUTION THEREOF, AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. SUCH SHARES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION 

THEREFROM UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS. COPIES OF THE AGREEMENT COVERING THE PURCHASE OF THESE SHARES AND RESTRICTING
THEIR TRANSFER MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF THE COMPANY AT THE PRINCIPAL EXECUTIVE OFFICES OF THE COMPANY. 

12. Warrants Transferable. Subject to compliance with the terms and conditions of this Section 12, this Warrant and all rights
hereunder are transferable, in whole or in part, without charge to the holder hereof (except for transfer taxes), upon surrender of this Warrant properly endorsed or accompanied by written instructions of transfer. With respect to any offer, sale or
other disposition of this Warrant or any Shares acquired pursuant to the exercise of this Warrant prior to registration of such Warrant or Shares, the holder hereof agrees to give written notice to the Company prior thereto, describing briefly the
manner thereof, together with a written opinion of such holder’s counsel, or other evidence, if requested by the Company, to the effect that such offer, sale or other disposition may be effected without registration or qualification (under the
Act as then in effect or any federal or state securities law then in effect) of this Warrant or the Shares and indicating whether or not under the Act certificates for this Warrant or the Shares to be sold or otherwise disposed of require any
restrictive legend as to applicable restrictions on transferability in order to ensure compliance with such law. Upon receiving such written notice and reasonably satisfactory 

  
 -4- 

 
opinion or other evidence, if so requested, the Company, as promptly as practicable, shall notify such holder that such holder may sell or otherwise dispose of this Warrant or such Shares, all in
accordance with the terms of the notice delivered to the Company. If a determination has been made pursuant to this Section 12 that the opinion of counsel for the holder or other evidence is not reasonably satisfactory to the Company, the
Company shall so notify the holder promptly with details thereof after such determination has been made. Each certificate representing this Warrant or the Shares transferred in accordance with this Section 12 shall bear a legend as to the
applicable restrictions on transferability in order to ensure compliance with such laws, unless in the aforesaid opinion of counsel for the holder, such legend is not required in order to ensure compliance with such laws. The Company may issue stop
transfer instructions to its transfer agent in connection with such restrictions. 
 13. Rights of Stockholders. No holder of this
Warrant shall be entitled, as a Warrant holder, to vote or receive dividends or be deemed the holder of the Shares or any other securities of the Company which may at any time be issuable on the exercise hereof for any purpose, nor shall anything
contained herein be construed to confer upon the holder of this Warrant, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting
thereof, or to give or withhold consent to any corporate action (whether upon any recapitalization, issuance of stock, reclassification of stock, change of par value, consolidation, merger, conveyance, or otherwise) or to receive notice of meetings,
or to receive dividends or subscription rights or otherwise until the Warrant shall have been exercised and the Shares purchasable upon the exercise hereof shall have become deliverable, as provided herein. 

14. Expiration of Warrant; Notice of Certain Events Terminating This Warrant. 

(a) This Warrant shall expire and shall no longer be exercisable upon the earlier to occur of: 

(i) 5:00 p.m., California local time, on April 20, 2017; 

(ii) Any Change of Control in which the holders of Series D-1 Preferred Stock of the Company
receive or would receive in respect thereof any combination of cash and freely-tradable equity securities registered under the Securities Exchange Act of 1934, as amended, and listed on the New York or American Stock Exchange or the Nasdaq National
Market and the aggregate value thereof shall equal at least the Series D-1 Liquidation Preference (as defined in Section 4.2.2(a) of the Seventh Amended and Restated Certificate of Incorporation, as
amended from time to time); or 
 (iii) The initial public offering of the Company’s Common Stock pursuant to a firm commitment
underwriting in which all shares of Preferred Stock are automatically converted into Common Stock; provided that the holders of a majority of the shares of Common Stock issued or issuable on exercise of all Warrants issued pursuant to
the Note Purchase Agreement consent in writing to the termination of all Warrants issued under the Note Purchase Agreement. 
 (b) The
Company shall provide at least ten (10) days prior written notice of any event set forth in Section 14(a)(ii) or (iii). 
 (c) If
the fair market value of one Share exceeds the Exercise Price immediately prior to the time of a termination provided for under Section 14(a), then, to the extent not then exercised, this Warrant shall be deemed automatically exercised pursuant
to the cash-less exercise feature set forth in Section 4 hereof. 

  
 -5- 

 15. Notices. All notices and other communications required or permitted hereunder shall be
in writing, shall be effective when given, and shall in any event be deemed to be given upon receipt or, if earlier, (a) five (5) days after deposit with the U.S. Postal Service or other applicable postal service, if delivered by first
class mail, postage prepaid, (b) upon delivery, if delivered by hand, (c) one business day after the business day of deposit with Federal Express or similar overnight courier, freight prepaid or (d) one business day after the business
day of facsimile transmission, if delivered by facsimile transmission with copy by first class mail, postage prepaid, and shall be addressed (i) if to the Holder, at the Holder’s address as set forth on the Schedule of Investors to the
Note Purchase Agreement, and (ii) if to the Company, at the address of its principal corporate offices (attention: President) or at such other address as a party may designate by ten days advance written notice to the other party pursuant to
the provisions above. 
 16. Governing Law. This Warrant and all actions arising out of or in connection with this Agreement shall be
governed by and construed in accordance with the laws of the State of California, without regard to the conflicts of law provisions of the State of California or of any other state. 

17. Rights and Obligations Survive Exercise of Warrant. Unless otherwise provided herein, the rights and obligations of the Company, of
the holder of this Warrant and of the holder of the Shares issued upon exercise of this Warrant, shall survive the exercise of this Warrant. 

Issued this         th day of             
2007. 
  

			
	INOGEN, INC.
		
	By:	 	  

		 	Kathy Odell
		 	Chief Executive Officer

  
 -6- 

 EXHIBIT A 

NOTICE OF EXERCISE 
  

			
	TO:	 	INOGEN, INC.
		 	  

		 	  

		 	Attention: President

 1. The undersigned hereby elects to purchase
                 Shares of                  pursuant to the terms of the attached
Warrant. 
 2. Method of Exercise (Please initial the applicable blank): 

 

	 	        	The undersigned elects to exercise the attached Warrant by means of a cash payment, and tenders herewith payment in full for the purchase price of the shares being purchased, together with all applicable transfer taxes,
if any. 

  

	 	        	The undersigned elects to exercise the attached Warrant by means of the net exercise provisions of Section 4 of the Warrant. 

3. Please issue a certificate or certificates representing said Shares in the name of the undersigned or in such other name as is specified
below: 
  

	
	  

	(Name)
	
	  

	
	  

	(Address)

 4. The undersigned hereby represents and warrants that the aforesaid Shares are being acquired for the account
of the undersigned for investment and not with a view to, or for resale, in connection with the distribution thereof, and that the undersigned has no present intention of distributing or reselling such shares and all representations and warranties
of the undersigned set forth in Section 10 of the attached Warrant (including Section 10 (e) thereof) are true and correct as of the date hereof. 
  

					
		 		 	  

		 		 	(Signature)
			
		 		 	  

		 		 	(Name)
			
	  
	 		 	  

	 (Date)
	 		 	(Title)

  

 EXHIBIT B 

FORM OF TRANSFER
 (To be
signed only upon transfer of Warrant) 
 FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto
                                         the
right represented by the attached Warrant to purchase                  shares of
                 of INOGEN, INC. to which the attached Warrant relates, and appoints
                     Attorney to transfer such right on the books of , with full power of substitution in the premises. 

 

			
	Dated:	 	  

  

			
	  

	(Signature must conform in all respects to name of Holder as specified on the face of the Warrant)
		
	 Address:
	 	  

		
		 	  

		
		 	  

  

	
	Signed in the presence of:EX-4.4

 Exhibit 4.4 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE
SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT
REQUIRED. 
 Void after 
 ,
2019 
 INOGEN, INC.

WARRANT TO PURCHASE SHARES 

This Warrant is issued
to                    (“Investor”) by INOGEN, INC., a Delaware corporation (the “Company”), pursuant to the terms
of that certain Series E Preferred Stock and Common Stock Warrant Purchase Agreement (the “Purchase Agreement”) of even date herewith, in connection with the Company’s issuance to the holder of this Warrant of
Series E Preferred Stock (the “Series E Preferred Stock”) and such Investor’s Capital Commitment under the Purchase Agreement. Terms used but not defined herein shall have the meaning ascribed to them in the Purchase
Agreement. 
 1. Purchase of Shares. Subject to the terms and conditions hereinafter set forth and set forth in the Purchase
Agreement, the holder of this Warrant is entitled, upon surrender of this Warrant at the principal office of the Company (or at such other place as the Company shall notify the holder hereof in writing), to purchase from the Company up
to                    fully paid and non-assessable Shares (as defined below). 

2. Definitions. 
 (a)
Exercise Price. The exercise price for the Shares shall be $0.01 per share (such price, as adjusted from time to time, is herein referred to as the “Exercise Price”). 

(b) Exercise Period. This Warrant shall be exercisable, in whole or in part, during the term commencing on the date hereof and ending
on the expiration of this Warrant pursuant to Section 14 hereof. 
 (c) The Shares. The term “Shares” shall mean
Common Stock. 
 (d) Change of Control. The term “Change of Control” means the (i) sale, transfer, exclusive
license or other disposition of all or substantially all of the Company’s assets; (ii) the consummation of the merger or consolidation of the Company or a subsidiary of the Company with or into another entity (except one in which the
holders of capital stock of the Company as constituted immediately prior to such merger or consolidation continue to hold at least 50% of the voting power of the capital stock of the Company or the surviving or acquiring entity in substantially the
same relative proportions); (iii) the closing of the acquisition, in one transaction or a series of related transactions, by a person or group of affiliated persons of 50% or more of the outstanding voting stock of the Company; provided,
however, that a transaction shall not constitute a Change of Control pursuant to this clause (iii): if its sole purpose is to change the domicile of the Company; and (iv) a liquidation, dissolution or winding up of the Company. 

 3. Method of Exercise. While this Warrant remains outstanding and exercisable in
accordance with Section 2 above, the holder may exercise, in whole or in part, the purchase rights evidenced hereby. Such exercise shall be effected by: 

(i) the surrender of the Warrant, together with a notice of exercise to the Secretary of the Company at its principal offices; and 

(ii) the payment to the Company of an amount equal to the aggregate Exercise Price for the number of Shares being purchased. 

4. Net Exercise. In lieu of cash exercising this Warrant, the holder of this Warrant may elect to receive shares equal to the value of
this Warrant (or the portion thereof being canceled) by surrender of this Warrant at the principal office of the Company together with notice of such election, in which event the Company shall issue to the holder hereof a number of Shares computed
using the following formula: 
  

					
		  		 	Y (A - B)
	X	  	=	 	      A

 Where: 

X - The number of Shares to be issued to the holder of this Warrant. 

Y - The number of Shares purchasable under this Warrant. 

A - The fair market value of one Share. 

B - The Exercise Price (as adjusted to the date of such calculations). 

For purposes of this Section 4, the fair market value of a Share shall mean the average of the closing bid and asked prices of Shares
quoted in the over-the-counter market in which the Shares are traded or the closing price quoted on any exchange on which the Shares are listed, whichever is applicable, as published in the Western Edition of The Wall Street Journal for the
ten (10) trading days prior to the date of determination of fair market value (or such shorter period of time during which such stock was traded over-the-counter or on such exchange). If the Shares are not traded on the over-the-counter market
or on an exchange, the fair market value shall be the price per Share that the Company could obtain from a willing buyer for Shares sold by the Company from authorized but unissued Shares, as such prices shall be determined in good faith by the
Company’s Board of Directors. 
 5. Certificates for Shares. Upon the exercise of the purchase rights evidenced by this Warrant,
one or more certificates for the number of Shares so purchased shall be issued as soon as practicable thereafter, and in any event within ten (10) days of the delivery of the subscription notice. 

6. Issuance of Shares. The Company covenants that the Shares, when issued pursuant to the exercise of this Warrant, will be duly and
validly issued, fully paid and nonassessable and free from all taxes, liens, and charges with respect to the issuance thereof. 

  
 -2- 

 7. Adjustment of Exercise Price and Number of Shares. The number of and kind of securities
purchasable upon exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time as follows: 
 (a)
Subdivisions, Combinations and Other Issuances. If the Company shall at any time prior to the expiration of this Warrant subdivide the Shares, by split-up or otherwise, or combine its Shares, or issue additional shares of its Shares as a
dividend, the number of Shares issuable on the exercise of this Warrant shall forthwith be proportionately increased in the case of a subdivision or stock dividend, or proportionately decreased in the case of a combination. Appropriate adjustments
shall also be made to the purchase price payable per share, but the aggregate purchase price payable for the total number of Shares purchasable under this Warrant (as adjusted) shall remain the same. Any adjustment under this Section 7(a) shall
become effective at the close of business on the date the subdivision or combination becomes effective, or as of the record date of such dividend, or in the event that no record date is fixed, upon the making of such dividend. 

(b) Reclassification, Reorganization and Consolidation. In case of any reclassification, capital reorganization, or change in the
capital stock of the Company (other than as a result of a subdivision, combination, or stock dividend provided for in Section 7(a) above), then the Company shall make appropriate provision so that the holder of this Warrant shall have the right
at any time prior to the expiration of this Warrant to purchase, at a total price equal to that payable upon the exercise of this Warrant, the kind and amount of shares of stock and other securities and property receivable in connection with such
reclassification, reorganization, or change by a holder of the same number of Shares as were purchasable by the holder of this Warrant immediately prior to such reclassification, reorganization, or change. In any such case appropriate provisions
shall be made with respect to the rights and interest of the holder of this Warrant so that the provisions hereof shall thereafter be applicable with respect to any shares of stock or other securities and property deliverable upon exercise hereof,
and appropriate adjustments shall be made to the purchase price per share payable hereunder, provided the aggregate purchase price shall remain the same. 

(c) Notice of Adjustment. When any adjustment is required to be made in the number or kind of shares purchasable upon exercise of the
Warrant, or in the Exercise Price, the Company shall promptly notify the holder of such event and of the number of Shares or other securities or property thereafter purchasable upon exercise of this Warrant. 

8. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of
this Warrant, but in lieu of such fractional shares the Company shall make a cash payment therefor on the basis of the Exercise Price then in effect. 

9. Representations of the Company. The Company represents that all corporate actions on the part of the Company, its officers,
directors and stockholders necessary for the sale and issuance of this Warrant have been taken. 
 10. Representations and Warranties by
the Holder. The Holder represents and warrants to the Company as follows: 
 (a) This Warrant and the Shares issuable upon exercise
thereof are being acquired for its own account, for investment and not with a view to, or for resale in connection with, any distribution or public offering thereof within the meaning of the Securities Act of 1933, as amended (the “Act”).
Upon exercise of this Warrant, the Holder shall, if so requested by the Company, confirm in writing, in a form satisfactory to the Company, that the securities issuable upon exercise of this Warrant are being acquired for investment and not with a
view toward distribution or resale. 
 (b) The Holder understands that the Warrant and the Shares have not been registered under the Act by
reason of their issuance in a transaction exempt from the registration and prospectus delivery requirements of the Act pursuant to Section 4(2) thereof, and that they must be held by the Holder 

  
 -3- 

 
indefinitely, and that the Holder must therefore bear the economic risk of such investment indefinitely, unless a subsequent disposition thereof is registered under the Act or is exempted from
such registration. The Holder further understands that the Warrant Shares have not been qualified under the California Securities Law of 1968 (the “California Law”) by reason of their issuance in a transaction exempt from the qualification
requirements of the California Law pursuant to Section 25102(f) thereof, which exemption depends upon, among other things, the bona fide nature of the Holder’s investment intent expressed above. 

(c) The Holder has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of
the purchase of this Warrant and the Shares purchasable pursuant to the terms of this Warrant and of protecting its interests in connection therewith. 

(d) The Holder is able to bear the economic risk of the purchase of the Shares pursuant to the terms of this Warrant. 

(e) The Holder is an “accredited investor” as such term is defined in Rule 501 of Regulation D promulgated under the Act. 

11. Restrictive Legend. 

The Shares (unless registered under the Act) shall be stamped or imprinted with a legend in substantially the following form: 

THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR
DISTRIBUTION THEREOF, AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. SUCH SHARES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER THE ACT AND ANY APPLICABLE STATE
SECURITIES LAWS. COPIES OF THE AGREEMENT COVERING THE PURCHASE OF THESE SHARES AND RESTRICTING THEIR TRANSFER MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF THE COMPANY AT THE
PRINCIPAL EXECUTIVE OFFICES OF THE COMPANY. 
 12. Warrants Transferable. Subject to compliance with the terms and conditions of this
Section 12, this Warrant and all rights hereunder are transferable, in whole or in part, without charge to the holder hereof (except for transfer taxes), upon surrender of this Warrant properly endorsed or accompanied by written instructions of
transfer. With respect to any offer, sale or other disposition of this Warrant or any Shares acquired pursuant to the exercise of this Warrant prior to registration of such Warrant or Shares, the holder hereof agrees to give written notice to the
Company prior thereto, describing briefly the manner thereof, together with a written opinion of such holder’s counsel, or other evidence, if requested by the Company, to the effect that such offer, sale or other disposition may be effected
without registration or qualification (under the Act as then in effect or any federal or state securities law then in effect) of this Warrant or the Shares and indicating whether or not under the Act certificates for this Warrant or the Shares to be
sold or otherwise disposed of require any restrictive legend as to applicable restrictions on transferability in order to ensure compliance with such law. Upon receiving such written notice and reasonably satisfactory opinion or other evidence, if
so requested, the Company, as promptly as practicable, shall notify such holder that such holder may sell or otherwise dispose of this Warrant or such Shares, all in accordance with the terms of the notice delivered to the Company. If a
determination has been made pursuant to this Section 12 that the opinion of counsel for the holder or other evidence is not reasonably satisfactory to the Company, the 

  
 -4- 

 
Company shall so notify the holder promptly with details thereof after such determination has been made. Each certificate representing this Warrant or the Shares transferred in accordance with
this Section 12 shall bear a legend as to the applicable restrictions on transferability in order to ensure compliance with such laws, unless in the aforesaid opinion of counsel for the holder, such legend is not required in order to ensure
compliance with such laws. The Company may issue stop transfer instructions to its transfer agent in connection with such restrictions. 

13. Rights of Stockholders. No holder of this Warrant shall be entitled, as a Warrant holder, to vote or receive dividends or be deemed
the holder of the Shares or any other securities of the Company which may at any time be issuable on the exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon the holder of this Warrant, as such, any of the
rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action (whether upon any recapitalization,
issuance of stock, reclassification of stock, change of par value, consolidation, merger, conveyance, or otherwise) or to receive notice of meetings, or to receive dividends or subscription rights or otherwise until the Warrant shall have been
exercised and the Shares purchasable upon the exercise hereof shall have become deliverable, as provided herein. 
 14. Expiration of
Warrant; Notice of Certain Events Terminating This Warrant. 
 (a) This Warrant shall expire and shall no longer be exercisable upon the
earlier to occur of: 
 (i) 5:00 p.m., California local time, on February 26, 2019; 

(ii) Any Change of Control in which the holders of Series E Preferred Stock of the Company receive or would receive in respect thereof
any combination of cash and freely-tradable equity securities registered under the Securities Exchange Act of 1934, as amended, and listed on the New York or American Stock Exchange or the Nasdaq National Market and the aggregate value thereof shall
equal at least the Series E Liquidation Preference (as defined in Section 4.2.2 of the Eighth Amended and Restated Certificate of Incorporation, as amended from time to time); or 

(iii) The initial public offering of the Company’s Common Stock pursuant to a firm commitment underwriting in which all shares of
Preferred Stock are automatically converted into Common Stock; provided that the holders of a majority of the shares of Common Stock issued or issuable on exercise of all Warrants issued pursuant to the Purchase Agreement consent in writing to the
termination of all Warrants issued under the Purchase Agreement. 
 (b) The Company shall provide at least ten (10) days prior written
notice of any event set forth in Section 14(a)(ii) or (iii). 
 (c) If the fair market value of one Share exceeds the Exercise Price
immediately prior to the time of a termination provided for under Section 14(a), then, to the extent not then exercised, this Warrant shall be deemed automatically exercised pursuant to the cash-less exercise feature set forth in Section 4
hereof. 
 15. Notices. All notices and other communications required or permitted hereunder shall be in writing, shall be effective
when given, and shall in any event be deemed to be given upon receipt or, if earlier, (a) five (5) days after deposit with the U.S. Postal Service or other applicable postal service, if delivered by first class mail, postage prepaid,
(b) upon delivery, if delivered by hand, (c) one business day after the 

  
 -5- 

 
business day of deposit with Federal Express or similar overnight courier, freight prepaid or (d) one business day after the business day of facsimile transmission, if delivered by facsimile
transmission with copy by first class mail, postage prepaid, and shall be addressed (i) if to the Holder, at the Holder’s address as set forth on the Schedule of Investors to the Purchase Agreement, and (ii) if to the Company, at the
address of its principal corporate offices (attention: President) or at such other address as a party may designate by ten days advance written notice to the other party pursuant to the provisions above. 

16. Governing Law. This Warrant and all actions arising out of or in connection with this Agreement shall be governed by and construed
in accordance with the laws of the State of California, without regard to the conflicts of law provisions of the State of California or of any other state. 

17. Rights and Obligations Survive Exercise of Warrant. Unless otherwise provided herein, the rights and obligations of the Company, of
the holder of this Warrant and of the holder of the Shares issued upon exercise of this Warrant, shall survive the exercise of this Warrant. 

Issued this      day of
                2009. 
  

	
	INOGEN, INC.
	
	  

	 Raymond Huggenberger

	 Chief Executive Officer

  
 -6- 

 EXHIBIT A 

NOTICE OF EXERCISE 
  

			
	TO:	 	INOGEN, INC.
		 	  

		 	  

		 	Attention: President

 1. The undersigned hereby elects to
purchase                Shares of                pursuant to the terms of the attached
Warrant. 
 2. Method of Exercise (Please initial the applicable blank): 

 

	 	        	The undersigned elects to exercise the attached Warrant by means of a cash payment, and tenders herewith payment in full for the purchase price of the shares being purchased, together with all applicable transfer taxes,
if any. 

  

	 	        	The undersigned elects to exercise the attached Warrant by means of the net exercise provisions of Section 4 of the Warrant. 

3. Please issue a certificate or certificates representing said Shares in the name of the undersigned or in such other name as is specified
below: 
  

	
	  

	(Name)
	
	  

	
	  

	(Address)

 4. The undersigned hereby represents and warrants that the aforesaid Shares are being acquired for the account
of the undersigned for investment and not with a view to, or for resale, in connection with the distribution thereof, and that the undersigned has no present intention of distributing or reselling such shares and all representations and warranties
of the undersigned set forth in Section 10 of the attached Warrant (including Section 10 (e) thereof) are true and correct as of the date hereof. 
  

					
		 		 	  

		 		 	(Signature)
			
		 		 	  

		 		 	(Name)
			
	  
	 		 	  

	 (Date)
	 		 	(Title)

 EXHIBIT B 

FORM OF TRANSFER 
 (To be
signed only upon transfer of Warrant) 
 FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto
                     the right represented by the attached Warrant to purchase
                 shares of                  of INOGEN, INC. to which the attached Warrant
relates, and appoints                  Attorney to transfer such right on the books of
                , with full power of substitution in the premises. 
  

			
	Dated:	 	  

  

			
	  

	(Signature must conform in all respects to name of Holder as specified on the face of the Warrant)
		
	Address:	 	  

		
		 	  

		
		 	  

  

	
	 Signed in the presence of:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}]]